Furthermore, somatic mutations in genes like EPAS1 (encoding HIF-2α) and ATRX have been implicated in tumor development and aggressiveness, broadening the genetic landscape of PPGLs and highlighting the heterogeneity even within tumor subtypes [6,7]. The gene discussed is EPAS1; the disease is neoplasm.